Scientific advancements in personalized medicine have given
life to a body of knowledge that can improve patient outcomes, reduce the cost
of health care and eliminate inefficiencies that now plague our health care
system. But in order to ensure that clinicians, researchers and patients
realize these benefits, this new way of conceptualizing medicine must be
nurtured and applied within a carefully constructed regulatory and
reimbursement environment. In collaboration with our members, thought leaders,
and other stakeholders in personalized medicine, PMC facilitates the
development of public policies that allow for the timely and effective
application and advancement of personalized medicine and advocates for those
policies. Though our public policy work, PMC seeks to:
The work described above is completed during PMC Public
Policy Committee meetings and the deliberations of that group. During meetings of the public policy
committee, members develop specific policy positions and the strategies by
which these positions are communicated to target audiences, which often include
branches of the federal government and other non-governmental agencies. J.
Brian Munroe of Endo Pharmaceuticals chairs the 2014 committee.”
PMC members shape and advance the future of personalized medicine.
» Sign Up Today
Education + Advocacy looks at public views of personalized medicine.
» View Current Issue